Gerald E. Archer

27 papers receiving 1.3k citations

Hit Papers

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study 2015 · 313 citations
3132015202620182022100200300

Peers

Gerald E. Archer
Comparison fields: 5 of 75
  • Genetics 609
  • Immunology 545
  • Oncology 629
  • Radiology, Nuclear Medicine and Imaging 236
  • Structural Biology 11
Replace Elias Sayour with:
Elias Sayour United States
Chien‐Tsun Kuan United States
Tina Verschuere Belgium
Christian J. Davidson United States
Yoshihiro Otani Japan
Giedre Krenciute United States
Diego Alvarado United States
Patrick C. Gedeon United States
Kiek Verrijp Netherlands
Björn Schneider Germany
Gerald E. Archer relative to Elias Sayour United States Elias Sayour's profile →
Citations per field
00.5×1.5×2.4×
Elias Sayour · 1×
Citations per year

Countries citing papers authored by Gerald E. Archer

Since Specialization
Citations

This map shows the geographic impact of Gerald E. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald E. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald E. Archer more than expected).

Fields of papers citing papers by Gerald E. Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald E. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald E. Archer. The network helps show where Gerald E. Archer may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerald E. Archer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerald E. Archer Line = papers co-authored together Gerald E. Archer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
Hit paper breakdown →
2015313
2 2010279
3 2008145
4 2012113
5 199180
6 198961
7
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.
199949
8 201845
9
Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
199044
10 199324
11 199722
12
Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
199022
13 198620
14 199619
15 201313
16 201911
17 199610
18 201610
19 20229
20
Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
19957

About Gerald E. Archer

Gerald E. Archer is a scholar working on Genetics, Immunology, Biotechnology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Glioma Diagnosis and Treatment (10 papers), CAR-T cell therapy research (5 papers), RNA Interference and Gene Delivery (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Genetics (609 citations), Immunology (545 citations), Oncology (629 citations), Radiology, Nuclear Medicine and Imaging (236 citations) and Structural Biology (11 citations). Gerald E. Archer has collaborated with scholars based in United States, Australia and Norway. Frequent co-authors include Darell D. Bigner, John H. Sampson, Henry S. Friedman, David A. Reardon, Thomas F. Tedder, Smita K. Nair, Roger E. McLendon, Amy B. Heimberger, Michael R. Zalutsky and James E. Herndon. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Cancer Immunology Immunotherapy, Current Protocols in Immunology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026